461. Deputy Louise O'Reilly asked the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, if a company (details supplied) or its insurers have met with his Department, the HSE, the Health Products Regulatory Authority or other Departments, offices or statutory bodies in relation to the breast implants which are now known to cause breast implant associated anaplastic large cell lymphoma to discuss their possible ill effect on those that received them [51882/19]

Summary

461. Deputy Louise O'Reilly asked the Minister for Health further to Parliamentary Question Nos. 320, 321, 322, 324 and 325 of 26 November 2019, if a company (details supplied) or its insurers have met with his Department, the HSE, the Health Products Regulatory Authority or other Departments, offices or statutory bodies in relation to the breast implants which are now known to cause breast implant associated anaplastic large cell lymphoma to discuss their possible ill effect on those that received them [51882/19]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Cancer Awareness

  xml · EN · 10 December 2019

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.